Tel: +263 242 708020, +263 242 705946 rsc@medsch.uz.ac.zw

Funding Opportunities

 

New 2025 ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries

This Request for Proposals (RFP) from Cures Within Reach (CWR) is for our ReGRoW program, providing grants for clinical repurposing trials led by under resourced researchers and clinicians based in low and lower-middle income countries (LMICs), as defined by the World Bank. This RFP is seeking clinical repurposing trials to address any unsolved disease facing patients in LMICs. CWR is interested in building capacity for clinical research in LMICs while finding available and affordable treatments for patients in LMICs through repurposing research. While this RFP is accepting clinical repurposing trials addressing any unsolved disease, CWR has a preference for trials that address high disease burden (see https://ourworldindata.org/burden-of-disease) whether non-communicable diseases; communicable diseases; maternal, neonatal and nutritional diseases; or injuries.

The LOI submission deadline is 11:59pm U.S. Eastern Time on March 28, 2025.

For more information, click: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cureswithinreach.org/wp-content/uploads/2025/02/CWR-ReGRoW-RFP-2025.pdfor https://www.cureswithinreach.org/programs/funding-opportunities-rfps/

 

New Seed Grant for New African Principal Investigators (SG-NAPI)

With the support of the German Federal Ministry of Education and Research (BMBF), UNESCO-TWAS launched a new programme to strengthen the capacity of African countries lagging in science and technology. The programme is aimed at early career researchers who have obtained their PhD abroad and have recently returned or will shortly return to an academic position in their home country. Grants are awarded to promising high-level research projects in Agriculture, Biology, Chemistry, Earth sciences, Engineering, Information Computer Technology, Mathematics, Medical Sciences and Physics carried out in African countries lagging in science and technology identified by TWAS.

Due date: 27 March 2025

For more information, click: https://twas.org/opportunity/seed-grant-new-african-principal-investigators-sg-napi

 

Global Health EDCTP3 Calls for Proposals 2025

The Global Health European & Developing Countries Clinical Trials Partnership (EDCTP3) will open new calls at the end of January 2025 to fund proposals for clinical research, capacity building, and/or networking proposals in EDCTP3’s priority areas.

The 2025 Work Programme includes four calls covering seven topics:

  • Vaccines for reducing the disease burden of Tuberculosis in sub-Saharan Africa;
  • Malaria therapeutics and clinical development of new antimalarial candidates;
  • Strategic Training Hubs covering Biostatistics, Epidemiology and Modelling:
  • Epidemic Preparedness;
  • Diarrhoeal Diseases in the context of climate and health;
  • Transformative Innovations in global health.

Due date: Submission of short proposals 20 March 2025; and full proposals (2nd phase) by September 2025.

For more information, click:

https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en

 

New Innovative Data and Modeling Approaches to Measure Women’s Health

This Grand Challenge on Innovative Data and Modeling Approaches to Measure Women’s Health seeks to advance innovative ways to measure women’s health by either developing new measurement models or adapting existing ones to better capture the full scope of women’s health burdens and progress. This Grand Challenge prioritizes solutions that leverage data sources that are existing or under development rather than relying on new, large-scale data collection efforts, ensuring sustainability and feasibility.

Applicants are encouraged to build upon existing work, whether by enhancing ongoing projects with a stronger gender-sensitive approach, refining existing models, or expanding available datasets in ways that align with the Challenge’s objectives

Deadline: Mar 25, 2025, 11:30 am PDT

Award budget: $150,000

For more information click: https://gcgh.grandchallenges.org/challenge/innovative-data-and-modeling-approaches-measure-womens-health

 

New Enhancing HIV and TB Diagnosis: Adjunct Technologies for Sample Collection and Processing

TB diagnosis faces significant gaps. Due to its distinctive cell wall structure and resistance to traditional chemical lysis methods, Mycobacterium tuberculosis (MTB) typically requires instrumented mechanical lysis to achieve high sensitivity in molecular diagnostic assays (“New Manual Quantitative Polymerase Chain Reaction Assay Validated on Tongue Swabs Collected and Processed in Uganda Shows Sensitivity That Rivals Sputum-based Molecular 1 Tuberculosis Diagnostics”). Unlike diseases such as HIV and malaria, there are currently no instrument-free, true PoC molecular diagnostic tools that have adequate performance for detection of TB. While simple tuberculosis lipoarabinomannan (TB LAM) tests represent another unique solution for MTB detection using noninvasive sampling with urine, diagnostic accuracy is modest for PLHIV and otherwise poor. Expanding access to highly accurate testing, particularly in closer proximity to patients, is critical to ending the TB epidemic. To bridge these diagnostic gaps, developing adjunct technologies for sample collection, lysis, and preparation is essential. Pre-analytical solutions, such as simplified sample collection and stabilization and instrument free sample lysis specifically for TB could enable more reliable and consistent results while reducing reliance on complex laboratory infrastructure. By investing in these supporting technologies, diagnostic platforms can become more accessible, scalable, and effective in reaching underserved

Deadline: Mar 25, 2025, 11:30 am PDT

Award budget: $100,000 to $250,000 USD

For more information click: https://gcgh.grandchallenges.org/challenge/enhancing-hiv-and-tb-diagnosis-adjunct-technologies-sample-collection-and-processing

 

New Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings

We invite research proposals on HMB based on the clinical definition that focus on:

  1. Biological Mechanisms – Advancing understanding of the fundamental biology of HMB to identify targets for innovative diagnostics and treatments.
  2. Epidemiology and Impact – Assessing disease burden, patterns, and impact on gynecological health and quality of life in women in low-resource settings.
  3. Measurement and Standardization – Developing and validating improved methods for measuring HMB and establishing standardized research protocols to enable consistent and comparable studies across diverse populations and healthcare systems.
  4. Innovative Diagnostics – Proposing new technology or piloting the use of existing technology to identify causes of HMB in low resource settings, including the use of artificial intelligence. Technology should be easy to use and affordable.
  5. Treatment and Access – Evaluating the effectiveness, acceptability, and ways to increase access to treatment including hormonal contraceptives, to inform patient-centered care in low-resource settings.

Deadline: Mar 25, 2025, 11:30 am PDT

Award budget: $150,000

For more information click: https://gcgh.grandchallenges.org/challenge/accelerating-innovations-address-heavy-menstrual-bleeding-women-low-resource-settings

 

New Early Career Investigator Grant

The Ovarian Cancer Research Alliance is inviting Letters of Intent for the Early Career Investigator Grant.

The Early Career Investigator Grant (ECIG) is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer and/or related gynecologic cancers research on a path towards independence. The intent of these grants is to support a substantial time commitment to research and academic endeavors in ovarian cancer.

Deadline: Mar 26, 2025

Award budget: $150,000

For more information click: https://ocrahope.org/research/information-for-researchers/apply-for-a-grant/

 

New Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Deadline: 03 April 2025, 17:00 BST

Award budget: The annual expenditure for a Career Development Award is usually below £250,000 excluding the applicant’s salary.

For more information click: https://wellcome.org/grant-funding/schemes/career-development-awards?utm_source=email&utm_medium=o-&utm_campaign=2604844_Research%20Update%20-%20March%202025&dm_i=2PXJ,1JTWS,60YMVT,68OEA,1

 

New Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Deadline: 08 April 2025, 17:00 BST

Award budget: The average size of a Discovery Award is £3.5 million. Applications above £5 million will be subject to additional scrutiny.

For more information click: https://wellcome.org/grant-funding/schemes/discovery-awards?utm_source=email&utm_medium=o-&utm_campaign=2604844_Research%20Update%20-%20March%202025&dm_i=2PXJ,1JTWS,60YMVT,68OEA,1

 

New Request for proposals: ANH Academy Regional Collaboratives

Geographic focus: Africa and South Asia

ANH Academy aims to accelerate actions towards equitable and just food systems for nutrition and health, whilst confronting climate change and protecting nature, through interdisciplinary research, capability sharing and collaboration. We are seeking impactful institutions in Africa and South Asia, with excellence in research, a strong track record of advancing science-policy capabilities and promoting the uptake of evidence to inform policy, to establish regional collaborative partnerships, Regional Collaboratives (RCs). Competitive Regional Collaboratives will have high scientific credibility and legitimacy, as reflected by a demonstrable track record of producing robust, accurate and sound sources of knowledge in ways that are fair, ethical and transparent. They will have well-established stakeholder networks, and once established, will function with existing partners (London School of Hygiene and Tropical Medicine (lead), Tufts University, and University of Sheffield) as a unified overarching consortium of the ANH Academy. 

Deadline: 24 April and 25 August 2025

Award budget: Regional Collaboratives will be funded, with awards of up to £2.3 million each for a period of 48 months

For more information click: https://www.anh-academy.org/anh-academy/request-for-proposals-anh-academy-regional-collaboratives

 

New ICGEB-COMSTECH Scientific Cooperation Programme Research Grants

The ICGEB CRP Grants programme was established in 1988 and aims to stimulate collaborative research in Member States and with the ICGEB Component laboratories, promote training of young scientists, and facilitate the creation of appropriate research facilities. The programme supports research projects in basic science, human healthcare, industrial and agricultural biotechnology and bioenergy. A call for applications is launched yearly. Grants are awarded to contribute to the implementation of outstanding scientific research projects. An important element of successful applications is the feasibility of the proposed project within the designated timeframe (maximum 36 months). The maximum annual contribution from ICGEB is Euro 25,000.

Funds can only be used to cover expenditures directly relevant to the project. This may include purchasing consumable items, scientific literature and basic standard laboratory equipment. Travel and training costs can also be covered. Salaries of the Principal Investigators and infrastructural support (e.g., normal administrative and overhead expenses of the Institution, maintenance and rental of capital equipment, building, etc.) are not admissible and cannot be funded.

Deadline: 30 April 2025

For more information click: https://www.icgeb.org/grants/?utm_source=brevo&utm_campaign=nome-campagna&utm_medium=email

 

Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due dates: Letter of Intent is due June 29th, 2025, November 23rd, 2025

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

 

GenScript Life Science Research Grant Program

GenScript Life Science Research Grant Program is a new initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to those indicated below. This program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.

  • Gene and Cell Therapy Development
  • Antibody Drug Discovery
  • Vaccine Development

Deadline: 15 June, 15 September and 15 November 2025

Award budget: $100,000

For more information click: https://www.genscript.com/grantprogram.html

 

Research Grants on Education: Small

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications three times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Applications Open: Mid-February, 2025

Full Proposal Deadline: Mid-April, 2025

For more information click; https://www.spencer.org/grant_types/small-research-grant

 

New Mental Health Award: Advancing target validation for novel mental health drug discovery

This call will provide funding for validation activities for novel targets with a clear therapeutic concept and strong biological rationale related to early intervention in anxiety, depression and/or psychosis. Funded proposals will generate data supporting the target’s therapeutic potential in the development of new and improved pharmacological treatments.

Due date: 15 April, 2025

Award budget: Up to £700,000 per project

For more information click: https://wellcome.org/grant-funding/schemes/target-validation-mental-health

 

New Climate Impacts Awards: Unlocking urgent climate action by making the health effects of climate change visible

The aim of this scheme is to make the impacts of climate change on physical and mental health visible to drive urgent climate policy action at scale. We will fund transdisciplinary teams to deliver short-term, high-impact projects that maximise policy outcomes by combining evidence generation with influencing and engagement strategies.

Due date: 30 April, 2025

Award budget: Up to £2.5 million

For more information click: https://wellcome.org/grant-funding/schemes/target-validation-mental-health

 

New Development & Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions for people who use drugs. Primary outcomes of interest include the feasibility, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research. Interventions here may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition or transmission of HIV infection, or improve clinical outcomes for persons living with HIV.

Due date: May 7, 2025

Award budget: Applicants may request direct costs of up to $450,000 for three years. Although variations from year to year are permissible, in no case may any year be more than $225,000 in direct costs, and total direct costs for the entire project period may not exceed $450,000.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-329.html

 

New Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives:

1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and

2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.

Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIH’s Office of AIDS Research (OAR) as described in NOT-OD-20-018.

Due date: May 7, 2025

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-355.html

 

New 2025 Call For Proposals: HIV CURE

The aim of this call for proposals is to fund research projects exploring mechanisms or strategies that will contribute to achieve a cure or a remission for HIV. The candidate projects may explore mechanisms to target the viral reservoir or enhance immune driven control, the development of new therapeutic concepts as well as all the social sciences around HIV cure or remission. With this call, we aim to fund research ultimately leading to biomedical breakthroughs, social acceptance of cure interventions and promotion of an HIV cure available to the maximum of PLHIV worldwide.  This call for proposals is therefore aimed at all parties involved in the development and implementation of HIV cure. Researchers from different disciplines, representatives of PLHIV, HIV counsellors and physicians can submit a letter of intent describing the rationale, objectives, and relevance of their project in the context of this call for proposals.

Letter of Intent due date: May 17, 2025

Award budget: Proposal should have a budget between € 300k-600k.

For more information click: https://aidsfonds.org/news-stories/hiv-cure-call-for-scientific-proposals-2025/

 

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Due date: 22 May 2025, 17:00 BST

Award budget: Your salary and up to £400,000 for research expenses.

For more information click: https://wellcome.org/grant-funding/schemes/early-career-awards

 

Collaborative Research Network in Mental Health 2025 (CRN 2025)

The aim of the Collaborative Research Network in Mental Health is to bring together all relevant stakeholders to promote and advance research in mental health and ensure its application to policy and practice, informed by the National Mental Health Research Strategy.

This network will be co-produced with lived experience experts and will serve the mental health research community on an all-island basis, with an identity independent of any single institution.

The HRB will provide funding up to a maximum of €1,000,000 (inclusive of overheads) over 60 months for a single collaborative research network in mental health.

Due date: 30 May 2025

For more information click: https://www.hrb.ie/funding-scheme/collaborative-research-network-for-mental-health-2025/

 

Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing
The Bill & Melinda Gates Foundation and LifeArc are seeking innovative solutions to lower the cost of monoclonal antibody (mAb) manufacturing, enhancing accessibility in low- and middle-income countries. Applicants can choose between grants of up to $750,000 (Option A) for scalable mAb production innovations with an 18-month duration or smaller, flexible grants (Option B) for exploratory projects reviewed monthly. Deadlines for Option A are 31 January 2025, and 31 May 2025. This opportunity encourages proposals with scalable, impactful approaches. 
Due dates: 31 May 2025

For more information click: https://gcgh.grandchallenges.org/challenge/innovations-exceptionally-low-cost-monoclonal-antibody-mab-manufacturing

 

Takeda Investigator Initiated Research

The Investigator Initiated Research (IIR) program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest. For areas of interest click; https://www.takeda.com/science/research-and-development/partnerships/iir/?queryID=e9ccd12c65536eb082b568ba3398386a

The request types and definitions below are applicable for the Takeda Support Research portal. For other types of requests, please use the Takeda Support Navigator to direct you to the appropriate site

  • Clinical Research. Clinical research is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health related, biomedical, or behavioral outcomes. Rare Diseases, Neuroscience, Gastroenterology and Plasma Derived Therapies (excluding US): gma.research@takeda.com

Clinical Oncology: GMAO.evidence.generation@takeda.com

Vaccines: iir.takeda.vaccines.global@takeda.com

US (excluding Oncology): US.Medical.Research@takeda.com

  • Pre-Clinical Oncology Research. Pre-Clinical Oncology Research supports research using Takeda’s proprietary oncology compounds or oncology-related mouse models, antibodies or cell lines. Requests for materials are the primary purpose of this program; funding requests are rarely approved.

Preclinical Oncology: preclinicaloncology@takeda.com

  • Pre-Clinical/Non-Clinical Non-Oncology Research. Non-clinical testing is conducted at a stage of medicines development that uses animals and/or cells or tissues. It does not involve testing in humans.

Rare Diseases, Neuroscience, Gastroenterology and Plasma Derived Therapies (excluding US): gma.research@takeda.com

Vaccines: iir.takeda.vaccines.global@takeda.com

US (excluding Oncology): US.Medical.Research@takeda.com

Due date: N/A

For more information click; https://takeda.envisionpharma.com/ienv_takeda/visiontracker/portal/login.xhtml?pgm=isr&windowId=67a&windowid=cfe

 

New Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics, climate change) remain relevant.

Due date: 5 June 2025; 5 October 2025

Award budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html

 

New Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics, climate change) remain relevant.

Due dates: 16 June 2025; 16 October 2025

Award budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html

 

New Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics, climate change) remain relevant.

Due date: 16 June 2025; 16 October 2025

Award budget: A budget for direct costs of up to $50,000 per year may be requested.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html

 

New Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data or the secondary analysis of existing data. Applications may propose studies using either single or mixed methods. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.

Due date: June 17, 2025; October 20, 2025

Award Budget: Application budgets are limited to no more than $50,000 in direct costs per year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-370.html

 

New Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods, that break new ground, extend previous discoveries in new directions, or develop preliminary data in preparation for larger studies. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.

Due date: June 17, 2025; October 20, 2025

Award Budget: Application budgets are limited to a combined total of no more than $275,000 in direct costs for the two or three-year project period with no more than $200,000 in direct costs in a single year.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-369.html

 

New Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

This Notice of Funding Opportunity (NOFO) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other interested groups  is encouraged, but not required.

Due date: June 17, 2025; October 20, 2025

Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-371.html

 

Wellcome: Mental Health Award: Leveraging longitudinal data to transform early intervention in mental health

We are funding experts to unlock the potential of longitudinal datasets and develop innovative ways of identifying anxiety, depression and/or psychosis early. Successful teams will integrate cutting-edge analytics of longitudinal data with experimental research so that, in time, people may benefit from better targeted early interventions. We will define longitudinal data as any data collected over time with a minimum of three time-points. Longitudinal datasets include, but are not limited to: cohorts; electronic health records;  data from experimental research collected over time.

Award budget: £2-5 million per project

Due date: Applications open: 23 April and close 22 July 2025

For more information, click https://wellcome.org/grant-funding/schemes/mental-health-award-leveraging-longitudinal-data-transform-early-intervention#application-process-timeline-6aa9

 

SWOG Early Exploration & Development (SEED) Fund

Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). These awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early-stage clinical trials), small self-contained research projects, or development of research methodology/technology.

Award budget: $50,000 direct costs

Due date: 1 July 2025

For more information, click: https://thehopefoundation.org/funding-opportunities/swog-early-exploration-development-seed-fund/

 

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States.  Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Award budget: Maximum limit of $550,000

Concept Due date: Applications open: 15 July 2025

For more information, click: https://www.thrasherresearch.org/al-thrasher-award?lang=eng

 

Fellowships and Scholarships

 

New WHO TDR Clinical Research Leadership fellowship programme

The purpose of the CRL fellowship programme is to provide funding support to researchers and clinical trial staff from LMICs to acquire essential leadership skills in clinical research through placements in TPOs. The scheme targets mid-career clinical researchers or clinical trial staff who are employed by a legal entity in an LMIC where they are currently conducting clinical research activities in the scope of TDR and in a broad range of poverty-related infectious diseases, emerging infectious diseases, pandemic preparedness, antimicrobial resistance and Neglected Tropical Diseases (NTDs)2. TDR will fund selected fellows to be placed in TPOs to train and develop new research skills linked to target infectious diseases.

Due date: 30 March 2025

Award budget: $100,000 USD

For more information click: https://tdr.who.int/grants

 

New Two Doctorate Positions for African Students in Infectious Diseases, Microbiology, Legal Medicine, and Public Health at Sapienza University of Rome

The Istituto Superiore di Sanità (ISS) recognizes the strategic importance of research and higher education on health issues in collaboration between Italy and Africa. To contribute to this activity, ISS promotes the “Italy-Africa Research Doctorates” initiative and, in collaboration with Sapienza University of Rome, annually finances two research doctorate positions for students of African nationality at the PhD Course Advances in infectious diseases, microbiology, legal medicine and public health sciences of Sapienza University of Rome.

Due date: 31 March 2025

For more information click: https://euraxess.ec.europa.eu/worldwide/africa/news/two-doctorate-positions-african-students-infectious-diseases-microbiology

 

New SANTHE Path-to-Independence Award 2025 – SHARP

The Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) provides Path-to-Independence (PtI) awards designed to help promising junior researchers in the network develop their respective careers as principal investigators. We are now accepting applications for SANTHE HIV cure Acceleration Research Programme (SHARP) All proposed projects must address critical challenges in HIV cure.

Due date: 31 March 2025

Award budget: $100,000 USD

For more information click; https://www.cognitoforms.com/AHRI1/PathtoIndependenceAward2025SHARP

 

New Arturo Falaschi Short-term PhD, Post-doctoral and Smart Fellowships

The Arturo Falaschi ICGEB provides competitive fellows to PhD and Postdoctoral students.

Due dates: 31 March 2025

For more information click; https://www.icgeb.org/fellowship/?utm_source=brevo&utm_campaign=nome-campagna&utm_medium=email

 

New CFAs: Africa Epidemic Service Fellowship Program

The Africa Centres for Disease Control and Prevention is seeking applications for its Africa Epidemic Service Fellowship Program which targets qualified applicants from Africa Union Member states drawn from public health discipline, with an interest in practicing applied Epidemiology. AES Fellows will be selected from a wide variety of disciplines including Medicine, Veterinary Medicine, Nursing, Environmental Health, Occupational Health as well as other associated disciplines under public health. Successful applicants are leaders who aspire to master applied epidemiology and are willing to accept assignments in a wide range of public health topics across the 55 African Union Member States.

Deadline: 31 March 2025

For more information click; https://africacdc.org/african-epidemic-service-programme/#

 

New African STARS Fellowship Programme – Applications Now Open!

The Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University (South Africa) and the Institut Pasteur de Dakar (IPD) (Senegal) invite applications for the African STARS Fellowship Programme, in partnership with the Mastercard Foundation. This prestigious initiative is designed to train the next generation of African leaders in genomics, diagnostics, vaccine development, and biotechnology innovation.

Advanced and Translational Training (ATT) Fellowship (4 months)

  • Advanced genomics for public health
  • Genomic diagnostic design
  • Vaccine & biomanufacturing

Young Professional Programme (YPP) Fellowship (12 months)

  • Research management
  • Innovation & entrepreneurship
  • Infectious diseases R&D for diagnostics
  • Innovations to enhance patient outcomes in Africa

Deadline dates: 31 March 2025

For more information click: https://www.starsfellows.africa/apply/

 

The C.H.I.L.D.R.E.N! funding program

The C.H.I.L.D.R.E.N! funding program from the Jeffrey Modell Foundation supports research focused on children living with PI, while addressing healthcare disparities, especially in developing countries, through education, testing, diagnosis, and treatment. The focus is to investigate immunological disorders, infectious diseases, and initiatives to decrease infant mortality and ultimately improve the quality of life of children affected by Primary Immunodeficiency globally. Applications are open to primary immunodeficiency researchers at all career stages around the world. The Program provides up to 25,000 USD in funding for projects spanning up to 2 years.

Due date: Applications are accepted on a rolling basis throughout the year.

For more information, click: https://info4pi.org/medical/

 

Fulbright Foreign Student Program

The Fulbright Foreign Student Program awards scholarships to Zimbabwean university faculty and researchers for advanced degrees in the United States.  Candidates are funded for a maximum of two years.  Awards and university placements will be announced in March/April for programs beginning in August/September of each year.  Designed primarily to provide professional development and strengthen higher education, the Student Program is the largest Fulbright program in Africa.

Eligibility Requirements

  • Currently employed at a tertiary or research institution in Zimbabwe and committed to returning to work in academia upon completion of the program;
  • Completed prior academic study equivalent to at least a 4-year U.S. bachelor’s degree with a minimum 2.1 GPA or its equivalent;
  • Satisfactory test scores (TOEFL, GRE, GMAT, etc.). N.B. Test fees are paid for finalists by the Fulbright program; and

Application/Selection Process

After national selection, nominations are recommended to the Fulbright Foreign Scholarship Board for final review.  The Institute of International Education then seeks university placement of successful candidates.

Application Deadline: April 1, 2025

For more information, click: https://zw.usembassy.gov/fulbright-program/

Apply here: https://apply.iie.org/ffsp2026 

 

Applications for 2025 HIV Research Trust scholarships now open

The HIV Research Trust provides funding in resource-limited settings for early- to mid-career researchers working in all fields of HIV prevention, infection and treatment. Scholarships should enable the candidate to travel to another research unit (host institution) to acquire new skills and techniques which will develop the candidate’s career and strengthen capacity in the department in which they are based (home institution).

Examples of skills and techniques include: clinical management; clinical trial experience and practice; data and trial management; statistical expertise; acquisition of laboratory techniques and analyses; cell and molecular biology.

Scholarships of up to £15,000 GBP are available, for tuition fees, laboratory costs, materials (consumables and shipping), international travel, accommodation and subsistence. Scholarships are awarded annually, following a peer-review process led by HIV Research Trust trustees. 

Application Deadline: April 2, 2025

For more information, click: https://zealous.co/hivresearchtrust/opportunity/HIV-Research-Trust-Scholarships-2025/?dm_i=77XC%2CYJ3A%2C3BSTTR%2C4D6DF%2C1

Wellcome: Mental Health Award: Leveraging longitudinal data to transform early intervention in mental health

We are funding experts to unlock the potential of longitudinal datasets and develop innovative ways of identifying anxiety, depression and/or psychosis early. Successful teams will integrate cutting-edge analytics of longitudinal data with experimental research so that, in time, people may benefit from better targeted early interventions. We will define longitudinal data as any data collected over time with a minimum of three time-points. Longitudinal datasets include, but are not limited to: cohorts; electronic health records;  data from experimental research collected over time.

Award budget: £2-5 million per project

Due date: Applications open: 23 April and close 22 July 2025

For more information, click https://wellcome.org/grant-funding/schemes/mental-health-award-leveraging-longitudinal-data-transform-early-intervention#application-process-timeline-6aa9

SWOG Early Exploration & Development (SEED) Fund

Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). These awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early-stage clinical trials), small self-contained research projects, or development of research methodology/technology.

Award budget: $50,000 direct costs

Due date: 1 July 2025

For more information, click: https://thehopefoundation.org/funding-opportunities/swog-early-exploration-development-seed-fund/

E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States.  Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Award budget: Maximum limit of $550,000

Concept Due date: Applications open: 15 July 2025

For more information, click: https://www.thrasherresearch.org/al-thrasher-award?lang=eng

Fellowships and Scholarships

 

E-JUST TICAD 8 African Scholarships for STI – Fall 2025 Intake

Egypt-Japan University of Science and Technology (E-UST) invites applicants from African countries to apply for E-JUST postgraduate (MSc or PhD) under TICAD8 scholarship for fall 2025 international admission.

For more information; refer to the attachment.

 

Global Health EDCTP3 JU and contributing partners funded Strategic Training Hubs for Fellowships in Public Health covering Biostatistics, Epidemiology and Modelling

Following a pilot collaboration with Africa CDC for a joint fellowship call under EDCTP2, the Global Health EDCTP3 is proposing to renew the joint call for fellowships [1]. After taking stock of the lessons learnt from the first programme, a funders partnership will support a joint call, i) to increase the number of fellows trained and ii) to expand the breadth of skills offered and diversity hosting institutions involved. Thisrenewed joint call will include epidemiology and biostatistics and infectious disease modelling.

Deadline dates: 1st phase short proposals 20 March 2025 17:00:00 Brussels time; 2nd phase full proposals 02 September 2025 17:00:00 Brussels time

For more information click: https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en

 

AACR-EMD Serono “I’M IN” Oncodisparity Fellowships in Lung and Urothelial Cancers

The AACR-EMD Serono “I’M IN” Oncodisparity Fellowships in Lung and Urothelial Cancers represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research should specifically address disparities in oncology care in the area of non-small cell lung cancer (NSCLC) or advanced urothelial carcinoma care and address barriers leading to inequality of cancer care that exist in institutions and within society at large. The fellowship provides a one-year grant of $65,000 to support the salary and benefits of the fellow while working on mentored cancer disparities research project. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

Due date:For more information click; March 18, 2025 1:00 PM

https://www.aacr.org/grants/aacr-emd-serono-oncodisparity-fellowships-lung-and-urothelial-cancers/

 

The C.H.I.L.D.R.E.N! funding program

The C.H.I.L.D.R.E.N! funding program from the Jeffrey Modell Foundation supports research focused on children living with PI, while addressing healthcare disparities, especially in developing countries, through education, testing, diagnosis, and treatment. The focus is to investigate immunological disorders, infectious diseases, and initiatives to decrease infant mortality and ultimately improve the quality of life of children affected by Primary Immunodeficiency globally. Applications are open to primary immunodeficiency researchers at all career stages around the world. The Program provides up to 25,000 USD in funding for projects spanning up to 2 years.

Due date: Applications are accepted on a rolling basis throughout the year.

For more information, click: https://info4pi.org/medical/

 

Fulbright Foreign Student Program

The Fulbright Foreign Student Program awards scholarships to Zimbabwean university faculty and researchers for advanced degrees in the United States.  Candidates are funded for a maximum of two years.  Awards and university placements will be announced in March/April for programs beginning in August/September of each year.  Designed primarily to provide professional development and strengthen higher education, the Student Program is the largest Fulbright program in Africa.

Eligibility Requirements

  • Currently employed at a tertiary or research institution in Zimbabwe and committed to returning to work in academia upon completion of the program;
  • Completed prior academic study equivalent to at least a 4-year U.S. bachelor’s degree with a minimum 2.1 GPA or its equivalent;
  • Satisfactory test scores (TOEFL, GRE, GMAT, etc.). N.B. Test fees are paid for finalists by the Fulbright program; and

Application/Selection Process

After national selection, nominations are recommended to the Fulbright Foreign Scholarship Board for final review.  The Institute of International Education then seeks university placement of successful candidates.

Application Deadline: April 1, 2025

For more information, click: https://zw.usembassy.gov/fulbright-program/

Apply here: https://apply.iie.org/ffsp2026 

 

Applications for 2025 HIV Research Trust scholarships now open

The HIV Research Trust provides funding in resource-limited settings for early- to mid-career researchers working in all fields of HIV prevention, infection and treatment. Scholarships should enable the candidate to travel to another research unit (host institution) to acquire new skills and techniques which will develop the candidate’s career and strengthen capacity in the department in which they are based (home institution).

Examples of skills and techniques include: clinical management; clinical trial experience and practice; data and trial management; statistical expertise; acquisition of laboratory techniques and analyses; cell and molecular biology.

Scholarships of up to £15,000 GBP are available, for tuition fees, laboratory costs, materials (consumables and shipping), international travel, accommodation and subsistence. Scholarships are awarded annually, following a peer-review process led by HIV Research Trust trustees. 

Application Deadline: April 2, 2025

For more information, click: https://zealous.co/hivresearchtrust/opportunity/HIV-Research-Trust-Scholarships-2025/?dm_i=77XC%2CYJ3A%2C3BSTTR%2C4D6DF%2C1

 

Nestlé Foundation Research Grants

The Nestlé Foundation offers different award and grant categories, some of them using a modular approach, i.e. the Pilot Grant Program represents the starting grant module for a later Full Grant Research application. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):

  1. Training Grant
  2. Pilot Grant
  3. Full Grant (small / large)

At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

  • maternal and child nutrition, including breastfeeding and complementary feeding,
  • macro- and micronutrient deficiencies and imbalances,
  • interactions between infection and nutrition, and
  • nutrition education and health promotion.

Due date for Letter of Intent: N/A

For more information click; https://www.nestlefoundation.org/research.html

 

 

For Expired funding opportunities:

  Click here

CONTACT US

University of Zimbabwe
Faculty of Medicine and Health Sciences
Research Management Unit
Parirenyatwa Hospital Grounds

Tel: +263 242 708020, +263 242 705946

Email address

rscsacoreoffice@gmail.com

rsc@medsch.uz.ac.zw

Website

www.uzchsrsc.ac.zw

 Twitter

ttps://twitter.com/UZCHSRSC

Linkedin

https://www.linkedin.com/in/uz-fmhs-research-support-centre-995768267/

Research Management       Unit